Amerisourcebergen (ABC) Akcija Цена
Amerisourcebergen Цена
U poslednjih 19 godina prihod Amerisourcebergen rastao je 9,0 % godišnje i dostigao 337,40 Млрд USD. Zarada po akciji rasla je 15,1 % godišnje u poslednjih 19 godina. Za Amerisourcebergen neto marža od 1,0 % je uglavnom stabilna u odnosu na 0,7 % pre nekoliko godina. Po današnjoj ceni dividendni prinos iznosi otprilike 0,42 %. Odnos isplate je oko 17 % dobiti. Dividenda je rasla 17,3 % godišnje u poslednjih 16 godina. Konsenzusna 12-mesečna ciljana cena za Amerisourcebergen je 213,18 USD, oko ispod kurs za 38,8 %. Od 21 analitičara 14 preporučuje kupovinu — ukupni konsenzus je Kupi.
Cena akcije Amerisourcebergen
Pristupite ovim podacima preko Eulerpool API-ja
100.000 zahteva/mes. besplatno · bez kartice
Amerisourcebergen poslovni model i analiza akcije
Često postavljana pitanja o akciji Amerisourcebergen
AmerisourceBergen Corp is a leading global pharmaceutical sourcing and distribution company. Its business model primarily focuses on providing pharmaceutical products and services to various healthcare providers, including hospitals, pharmacies, and physicians. As a key player in the healthcare supply chain, AmerisourceBergen operates through three main segments: Pharmaceutical Distribution Services, Global Commercialization Services, and Animal Health. Through these segments, the company offers a comprehensive range of services, including sourcing, packaging, logistics, and technology solutions. AmerisourceBergen Corp collaborates with pharmaceutical manufacturers to ensure the efficient delivery of vital medications and healthcare products to patients worldwide.
AmerisourceBergen Corp primarily operates in the pharmaceutical distribution industry.
The main competitors of AmerisourceBergen Corp in the market include McKesson Corporation and Cardinal Health Inc. These companies are key players in the pharmaceutical distribution industry, providing similar services and products. AmerisourceBergen Corp competes with these rivals in terms of market share, customer relationships, and supply chain management. These competitors also operate on a global scale, catering to the needs of healthcare providers and pharmaceutical manufacturers. Overall, AmerisourceBergen faces strong competition from McKesson Corporation and Cardinal Health Inc in its efforts to maintain its position as a leading player in the pharmaceutical distribution market.
AmerisourceBergen Corp, founded in 2001, is a global healthcare solutions company based in the United States. It specializes in pharmaceutical sourcing and distribution services, serving both pharmaceutical manufacturers and healthcare providers. With its extensive network of distribution centers, AmerisourceBergen offers a wide range of products and services to support patient care and deliver vital medications. The company has a rich history of growth and innovation, expanding its operations globally and establishing itself as a leader in the healthcare industry. AmerisourceBergen continues to evolve and adapt to the changing needs of the healthcare landscape, striving to improve patient outcomes and advance the delivery of healthcare services.
AmerisourceBergen Corp, a leading global healthcare solutions company, has achieved several significant milestones. The company has consistently expanded its market reach through strategic acquisitions and partnerships, solidifying its position as a major player in the pharmaceutical distribution industry. AmerisourceBergen Corp has also demonstrated its commitment to innovation by adopting advanced technologies and enhancing its digital capabilities. Furthermore, the company's strong financial performance, consistent revenue growth, and successful execution of its business strategies have contributed to its continuous success and recognition as a Fortune 11 company. AmerisourceBergen Corp's dedication to serving the healthcare needs of patients and providing exceptional value to its customers have allowed it to become a trusted partner in the industry.
AmerisourceBergen Corp is primarily present in the United States, one of the largest pharmaceutical markets globally. With headquarters in Pennsylvania, the company operates in various regions across the US, including key cities like California, New York, Texas, and Florida. AmerisourceBergen provides pharmaceutical distribution and related services to a wide range of healthcare providers, including hospitals, pharmacies, and physician practices. With a strong presence across the American healthcare landscape, AmerisourceBergen Corp plays a vital role in ensuring the efficient and reliable distribution of pharmaceutical products throughout the United States.
AmerisourceBergen Corp represents a strong commitment to integrity, innovation, and collaboration. The company values client relationships and aims to provide superior service by fulfilling the healthcare needs of their customers. With a mission to improve patient access to pharmaceuticals and medical products, AmerisourceBergen Corp operates under the corporate philosophy that emphasizes reliable distribution networks, cutting-edge technology solutions, and industry expertise. By leveraging their extensive network, they work towards delivering exceptional value to healthcare providers and pharmaceutical manufacturers. AmerisourceBergen Corp strives to foster a culture of trust, integrity, and transparency, ensuring sustainable growth and success in the healthcare industry.
Analitičari trenutno postavljaju prosečnu ciljanu cenu 213,76 USD za akciju Amerisourcebergen (medijana: 213,18 USD), što znači -38,6 % u odnosu na poslednju cenu. Konsenzus se zasniva na 21 ocena.
20 analitičara trenutno ocenjuje akciju Amerisourcebergen: 13 preporučuje kupovinu, 7 držanje i 0 prodaju.
Po trenutnom kursu akcija Amerisourcebergen kotira 317,22 EUR (348,31 USD).
Akcija Amerisourcebergen (ABC) kotira na 8 berze, uključujući: NYSE (ABC), London (0HF3.L), SIX (Zürich) (ABGCHF.SW), XETRA (ABG.DE), Frankfurt (ABG.F), München (ABG.MU), Düsseldorf (ABG.DU).
AmerisourceBergen Corp is an international company based in the USA that specializes in providing innovative solutions in the healthcare industry. The company offers a wide range of products and services that enable healthcare facilities to operate more efficiently and improve patient care. The business model of AmerisourceBergen Corp is based on three main business areas: 1. Pharmaceutical Distribution: The company is one of the largest pharmaceutical distributors in North America and offers a wide range of products and services to meet the demand for pharmaceuticals and medications. This includes specialty pharmaceuticals, biosimilars, and generics. 2. Outsourcing Services: AmerisourceBergen offers a variety of outsourcing services, including medication manufacturing, supply chain support, and consultation and training for healthcare professionals. 3. Value Assessment: Lastly, AmerisourceBergen provides value assessment services that enable customers to better understand and communicate the impact and benefits of their products. Together, these three business areas form the foundation of AmerisourceBergen's business model and enable the company to offer a variety of products and services to improve the quality of patient care and efficiency in the healthcare industry. One example of the products offered by AmerisourceBergen is oncology therapies. The company is a major provider of cancer medications in North America. It also works closely with insurance companies and other partners to ensure that cancer patients have access to necessary treatments and services. This product is an example of how AmerisourceBergen combines its core business areas to meet the demand for innovative solutions in healthcare. SEO-optimized terms found in this text include "pharmaceutical distributors," "outsourcing services," "value assessment services," and "oncology therapies." These terms are used to clarify the topic of the text and increase traffic to the AmerisourceBergen website by being found by search engines. By using such key terms, the text also strengthens the online visibility of AmerisourceBergen and contributes to improving the company's online marketing strategy.
prihod od Amerisourcebergen je 337,40 Млрд USD. Ova cifra je zasnovana na trenutnim finansijskim podacima i odražava poslovne rezultate preduzeća.
dobit od Amerisourcebergen je 3,48 Млрд USD. Neto dobit pokazuje profitabilnost preduzeća nakon odbitka svih troškova.
Odnos cene i zarade (KGV) za Amerisourcebergen je trenutno 19,40. KGV poredi sadašnju cenu akcije sa zaradom po akciji i pomaže investitorima da procene valuaciju akcije Amerisourcebergen.
Odnos cene i prihoda (KUV) za Amerisourcebergen je trenutno 0,20. KUV poredi tržišnu kapitalizaciju sa godišnjim prihodima i služi kao metrika valuacije za akciju Amerisourcebergen.
Eulpool score kvaliteta za Amerisourcebergen je 8/10.
ISIN za Amerisourcebergen je US03073E1055. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.
WKN za Amerisourcebergen je 766149. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.
Ticker za Amerisourcebergen je ABC. Simbol tikera se koristi za trgovinu akcijama Amerisourcebergen na berzanskom tržištu.
Amerisourcebergen акција
Amerisourcebergen Peer grupa
Amerisourcebergen Тикер
Amerisourcebergen FIGI
Sve ključne metrke i detaljne analize Amerisourcebergen u dubinskoj analizi
Naša analiza akcija za akciju Amerisourcebergen uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije Amerisourcebergen. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: